$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000114519715000059 Filed on August 12, 2015

Income Statement

Concept	2015 Q3	2015 Q2	2014 Q2
Revenue	$71.39M	$60.55M	$57.58M
YoY Change	18.93%	5.17%	-4.19%
Cost Of Revenue	$39.82M	$30.04M	$36.25M
YoY Change	7.8%	-17.14%	8.99%
Gross Profit	$31.57M	$30.52M	$31.83M
YoY Change	-6.44%	-4.13%	18.63%
Gross Profit Margin	44.22%	50.4%	55.28%
Selling, General & Admin	$36.33M	$32.51M	$34.37M
YoY Change	7.61%	-5.42%	25.06%
% of Gross Profit	115.08%	106.52%	107.97%
Research & Development	$10.04M	$12.07M	$6.677M
YoY Change	40.19%	80.75%	29.05%
% of Gross Profit	31.79%	39.55%	20.98%
Depreciation & Amortization	$4.300M	$3.680M	$3.030M
YoY Change	40.07%	21.45%	5.94%
% of Gross Profit	13.62%	12.06%	9.52%
Operating Expenses	$46.37M	$44.57M	$41.05M
YoY Change	13.31%	8.6%	25.69%
Operating Profit	-$14.79M	-$14.06M	-$5.280M
YoY Change	414.39%	166.27%	-9.31%
Interest Expense	-$3.100M	-$3.200M	$300.0K
YoY Change	-16.22%	-1166.67%
% of Operating Profit
Other Income/Expense, Net	-$3.146M	-$3.193M	-$23.78M
YoY Change	-60.42%	-86.57%	419.31%
Pretax Income	-$17.94M	-$17.25M	-$29.06M
YoY Change	65.75%	-40.63%	179.39%
Income Tax	$44.00K	$15.00K	$52.00K
% Of Pretax Income
Net Earnings	-$18.93M	-$15.43M	-$29.11M
YoY Change	74.52%	-46.99%	176.75%
Net Earnings / Revenue	-26.51%	-25.49%	-50.56%
Basic Earnings Per Share
Diluted Earnings Per Share	-$332.2K	-$271.1K	-$525.3K
COMMON SHARES
Basic Shares Outstanding	56.90M shares	56.75M shares	55.41M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q3	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$145.5M	$145.1M	$175.5M
YoY Change	-0.61%	-17.32%	16.3%
Cash & Equivalents	$145.5M	$145.1M	$175.5M
Short-Term Investments
Other Short-Term Assets	$4.000M	$3.400M	$5.700M
YoY Change	17.65%	-40.35%	-13.64%
Inventory	$13.02M	$23.44M	$8.765M
Prepaid Expenses
Receivables	$31.80M	$31.83M	$41.80M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$194.3M	$203.8M	$231.8M
YoY Change	-5.94%	-12.08%	17.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.54M	$42.04M	$34.16M
YoY Change	13.54%	23.07%	16.45%
Goodwill	$2.403M	$37.54M	$37.54M
YoY Change	-93.6%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.384M	$4.687M	$5.919M
YoY Change	-20.19%	-20.81%	213.84%
Total Long-Term Assets	$98.78M	$96.56M	$93.50M
YoY Change	4.44%	3.28%	5.02%
TOTAL ASSETS
Total Short-Term Assets	$194.3M	$203.8M	$231.8M
Total Long-Term Assets	$98.78M	$96.56M	$93.50M
Total Assets	$293.1M	$300.4M	$325.3M
YoY Change	-2.68%	-7.66%	13.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.61M	$17.92M	$18.61M
YoY Change	-11.91%	-3.73%	62.66%
Accrued Expenses	$35.55M	$26.44M	$24.59M
YoY Change	40.98%	7.54%	21.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$6.200M	$23.87M
YoY Change	50.0%	-74.03%
Total Short-Term Liabilities	$59.44M	$52.68M	$71.20M
YoY Change	24.44%	-26.01%	110.32%
LONG-TERM LIABILITIES
Long-Term Debt	$173.9M	$172.2M	$165.9M
YoY Change	3.85%	3.83%	52.64%
Other Long-Term Liabilities	$3.619M	$2.921M	$1.521M
YoY Change	40.27%	92.04%	-32.28%
Total Long-Term Liabilities	$177.5M	$175.1M	$167.4M
YoY Change	4.41%	4.63%	50.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.44M	$52.68M	$71.20M
Total Long-Term Liabilities	$177.5M	$175.1M	$167.4M
Total Liabilities	$238.0M	$230.1M	$242.5M
YoY Change	7.76%	-5.09%	64.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$624.2M	-$605.3M	-$561.8M
YoY Change	9.01%	7.75%	11.74%
Common Stock	$57.00K	$57.00K	$55.00K
YoY Change	1.79%	3.64%	1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.13M	$70.26M	$77.88M
YoY Change
Total Liabilities & Shareholders Equity	$293.1M	$300.4M	$325.3M
YoY Change	-2.68%	-7.66%	13.69%

Cashflow Statement

Concept	2015 Q3	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$18.93M	-$15.43M	-$29.11M
YoY Change	74.52%	-46.99%	176.75%
Depreciation, Depletion And Amortization	$4.300M	$3.680M	$3.030M
YoY Change	40.07%	21.45%	5.94%
Cash From Operating Activities	$8.740M	$790.0K	$510.0K
YoY Change	81.33%	54.9%	-88.33%
INVESTING ACTIVITIES
Capital Expenditures	-$2.530M	-$250.0K	-$3.590M
YoY Change	-18.39%	-93.04%	120.25%
Acquisitions
YoY Change
Other Investing Activities	-$4.720M
YoY Change
Cash From Investing Activities	-$7.240M	-$250.0K	-$3.590M
YoY Change	133.55%	-93.04%	120.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-960.0K	-1.000M	33.01M
YoY Change	-96.89%	-103.03%	25292.31%
NET CHANGE
Cash From Operating Activities	8.740M	790.0K	510.0K
Cash From Investing Activities	-7.240M	-250.0K	-3.590M
Cash From Financing Activities	-960.0K	-1.000M	33.01M
Net Change In Cash	540.0K	-460.0K	29.93M
YoY Change	-101.85%	-101.54%	942.86%
FREE CASH FLOW
Cash From Operating Activities	$8.740M	$790.0K	$510.0K
Capital Expenditures	-$2.530M	-$250.0K	-$3.590M
Free Cash Flow	$11.27M	$1.040M	$4.100M
YoY Change	42.3%	-74.63%	-31.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56895050	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	INSULET CORP
	dei	Trading Symbol TradingSymbol	PODD
	podd	Allocationtoequityforconversionforthe2 Notes Allocationtoequityforconversionforthe2Notes	35638000	USD
	podd	Allocationtoequityforconversionforthe2 Notes Allocationtoequityforconversionforthe2Notes	0	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	4361000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	4997000	USD
CY2014Q2	podd	Interest Expense Debt And Gains Losses On Extinguishment Of Debt InterestExpenseDebtAndGainsLossesOnExtinguishmentOfDebt	22666000	USD
	podd	Interest Expense Debt And Gains Losses On Extinguishment Of Debt InterestExpenseDebtAndGainsLossesOnExtinguishmentOfDebt	26785000	USD
CY2015Q2	podd	Interest Expense Debt And Gains Losses On Extinguishment Of Debt InterestExpenseDebtAndGainsLossesOnExtinguishmentOfDebt	2912000	USD
	podd	Interest Expense Debt And Gains Losses On Extinguishment Of Debt InterestExpenseDebtAndGainsLossesOnExtinguishmentOfDebt	5801000	USD
CY2014Q4	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	2	customer
CY2015Q2	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	1	customer
CY2015Q2	podd	Number Of Financial Institution NumberOfFinancialInstitution	2	location
CY2015Q2	podd	Number Of Inches Of Tubing In Conventional Insulin Pump NumberOfInchesOfTubingInConventionalInsulinPump	42	in
CY2014	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	customer
CY2015Q2	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	customer
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	700000	USD
	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	customer
CY2014	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.24
	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.31
	podd	Product Warranty Term ProductWarrantyTerm	P4Y
	podd	Return Period ReturnPeriod	P45D
CY2015Q2	podd	Warranty Expense Voluntary Recall WarrantyExpenseVoluntaryRecall	200000	USD
	podd	Warranty Expense Voluntary Recall WarrantyExpenseVoluntaryRecall	200000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14659000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17916000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	45719000	USD
CY2015Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37162000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39882000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31826000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24703000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26443000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P7Y
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	661798000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	675489000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8600000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4300000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9600000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5837000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5336000	USD
CY2014Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2258000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4883000	USD
CY2015Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1625000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3226000	USD
CY2014Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	192000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	338000	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	281000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	563000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5869000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3789000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2200000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8030735	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8030735	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8155181	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8155181	shares
CY2014Q4	us-gaap	Assets Assets	302156000	USD
CY2015Q2	us-gaap	Assets Assets	300393000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	208196000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	203829000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3380000	USD
CY2015Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	6235000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	5721000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	2263000	USD
CY2015Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	2315000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	9432000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5639000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	269000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	882000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	8550000	USD
CY2015Q2	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3524000	USD
CY2014Q2	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	300000	USD
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	600000	USD
CY2015Q2	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	400000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56299022	shares
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149727000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175545000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	151193000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145137000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	123141000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	108177000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	25818000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6056000	USD
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56876012	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56299022	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56876012	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	56000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	57000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36248000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	72601000	USD
CY2015Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	41213000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	69621000	USD
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	30000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	64000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	49000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	1600000	USD
CY2015Q2	us-gaap	Deferred Revenue DeferredRevenue	2300000	USD
CY2014Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	53000	USD
CY2015Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40000	USD
CY2014Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	348535	shares
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	32256000	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	29030000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4974000	USD
CY2015Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4411000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1554000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2088000	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7114000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	50300000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18836000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20599000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2656000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2665000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1488000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1496000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1806000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2190000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32900000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32900000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14064000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12301000	USD
CY2011	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	32900000	USD
CY2014Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18943000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18943000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23200000	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19512000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33771000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12856000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28685000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	37536000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	37536000	USD
CY2014Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	35765000	USD
	us-gaap	Gross Profit GrossProfit	68573000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	34375000	USD
	us-gaap	Gross Profit GrossProfit	67182000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-29059000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35138000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15395000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27177000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10534000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6876000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	355000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	534000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-699000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10336000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-422000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	147000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1006000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-632000	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3975000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	8464000	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3075000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	6268000	USD
CY2014Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1273000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2621000	USD
CY2015Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1006000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2012000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11992000	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19725000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	13099000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	23435000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	853000	USD
CY2015Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1465000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	254000	USD
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2245000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	29000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	60000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	41000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	77000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	218327000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	230138000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	302156000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	300393000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44296000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	52682000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	168994000	USD
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	172220000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32072000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1248000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5745000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4601000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-509000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2703000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-29111000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-35255000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-15432000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-27266000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23779000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27972000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3034000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6186000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	41045000	USD
	us-gaap	Operating Expenses OperatingExpenses	75739000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	46736000	USD
	us-gaap	Operating Expenses OperatingExpenses	88173000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5280000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7166000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-12361000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20991000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	16340000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2290000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2181000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2308000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2327000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	6080000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1154000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5291000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4687000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2774000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2921000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-890000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-625000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5890000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2427000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5745000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4601000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4022000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3431000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5339000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6489000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	194570000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3090000	USD
CY2014Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3100000	USD
CY2014Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2505000	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2614000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2661000	USD
CY2015Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3167000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	981000	USD
CY2015Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1566000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1633000	USD
CY2015Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1601000	USD
CY2014Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	445000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1127000	USD
CY2015Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	748000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1168000	USD
CY2014Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	-150000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	542000	USD
CY2015Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1254000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1721000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37069000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42040000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1804000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1180000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	160685000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1262000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2814000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6677000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13456000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12069000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20276000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1200000	USD
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1200000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-578025000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-605291000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	72013000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	141174000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	75588000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	136803000	USD
CY2014Q2	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	two
	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	two
CY2015Q2	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	two
	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	one
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14856000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28512000	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21811000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	39212000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8577000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9630000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	841750	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	869820	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	27.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7922000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	125420	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1555866	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8262000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1847669	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2879370	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.99
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.66
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	8039000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2589255	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.62
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	30.16
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	32.98
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6428000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M0D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M0D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	398745	shares
CY2014Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12600000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	83829000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	70255000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55425949	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55258419	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56808489	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56653430	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Nature of the Business</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Insulet Corporation, the "Company," is primarily engaged in the development, manufacturing and sale of its proprietary OmniPod Insulin Management System (the “OmniPod System”), an innovative, discreet and easy-to-use insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a unique disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the handheld, wireless Personal Diabetes Manager (“PDM”). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">42</font><font style="font-family:Arial;font-size:10pt;"> inches of tubing. In contrast, the OmniPod System features two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, “Neighborhood Diabetes”) in </font><font style="font-family:Arial;font-size:10pt;">June 2011</font><font style="font-family:Arial;font-size:10pt;">, in order to expand the Company’s full-suite diabetes management product offerings and obtain access to a larger number of insulin dependent patients. Through Neighborhood Diabetes, the Company is able to provide customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and has the ability to process claims as either durable medical equipment or through pharmacy benefits.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial sales of the OmniPod System began in the United States in </font><font style="font-family:Arial;font-size:10pt;">2005</font><font style="font-family:Arial;font-size:10pt;">. The Company sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The OmniPod System is currently available in multiple countries in Europe and in Canada.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting periods. The most significant estimates used in these financial statements include the valuation of stock-based compensation expense, accounts receivable, inventories, goodwill, deferred revenue, and equity instruments, the lives of property and equipment and intangible assets, as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001145197-15-000059-index-headers.html	Edgar Link	pending
0001145197-15-000059-index.html	Edgar Link	pending
0001145197-15-000059.txt	Edgar Link	pending
0001145197-15-000059-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
podd-20150630.xml	Edgar Link	completed
podd-20150630.xsd	Edgar Link	pending
podd-20150630_cal.xml	Edgar Link	unprocessable
podd-20150630_def.xml	Edgar Link	unprocessable
podd-20150630_lab.xml	Edgar Link	unprocessable
podd-20150630_pre.xml	Edgar Link	unprocessable
podd-2015x06x30_10xq.htm	Edgar Link	pending
podd-ex101_20150630x10q.htm	Edgar Link	pending
podd-ex102_20150630x10q.htm	Edgar Link	pending
podd-ex103_20150630x10q.htm	Edgar Link	pending
podd-ex104_20150630x10q.htm	Edgar Link	pending
podd-ex311_20150630x10q.htm	Edgar Link	pending
podd-ex312_20150630x10q.htm	Edgar Link	pending
podd-ex321_20150630x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2015 Q3 Form 10-Q Financial Statement

#000114519715000059 Filed on August 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2015 Q3 Form 10-Q Financial Statement

#000114519715000059 Filed on August 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd